277 related articles for article (PubMed ID: 25303115)
1. The transcorneal penetration of commercial ophthalmic formulations containing timolol maleate in rabbit eyes.
Fukuda M; Sasaki H
J Ocul Pharmacol Ther; 2015 Feb; 31(1):57-60. PubMed ID: 25303115
[TBL] [Abstract][Full Text] [Related]
2. [In vitro evaluation for corneal damages by anti-glaucoma combination eye drops using human corneal epithelial cell (HCE-T)].
Nagai N; Murao T; Oe K; Ito Y; Okamoto N; Shimomura Y
Yakugaku Zasshi; 2011; 131(6):985-91. PubMed ID: 21628988
[TBL] [Abstract][Full Text] [Related]
3. Polyquad-preserved travoprost/timolol, benzalkonium chloride (BAK)-preserved travoprost/timolol, and latanoprost/timolol in fixed combinations: a rabbit ocular surface study.
Liang H; Brignole-Baudouin F; Pauly A; Riancho L; Baudouin C
Adv Ther; 2011 Apr; 28(4):311-25. PubMed ID: 21424577
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of in vitro ocular surface cytotoxicity of a fixed combination of 0.5% timolol/1% dorzolamide eyedrop and its components with 0.005% benzalkonium chloride.
Ayaki M; Iwasawa A; Niwano Y
Biocontrol Sci; 2012; 17(3):115-20. PubMed ID: 23007102
[TBL] [Abstract][Full Text] [Related]
5. In vitro comparative toxicology of polyquad-preserved and benzalkonium chloride-preserved travoprost/timolol fixed combination and latanoprost/timolol fixed combination.
Brignole-Baudouin F; Riancho L; Liang H; Nakib Z; Baudouin C
J Ocul Pharmacol Ther; 2011 Jun; 27(3):273-80. PubMed ID: 21410334
[TBL] [Abstract][Full Text] [Related]
6. [Fixed combinations of glaucoma medications].
Călugăru D; Călugăru M
Oftalmologia; 2008; 52(3):23-31. PubMed ID: 19149113
[TBL] [Abstract][Full Text] [Related]
7. Cell viability score as an integrated indicator for cytotoxicity of benzalkonium chloride-containing antiglaucoma eyedrops.
Ayaki M; Iwasawa A; Niwano Y
Biocontrol Sci; 2012; 17(3):121-8. PubMed ID: 23007103
[TBL] [Abstract][Full Text] [Related]
8. [Contribution focused to clarify correlation between mixtures of the free amino acids with antiglaucomatics in influencing the IOP in rabbits after application into the conjunctival sac].
Oláh Z; Veselovský J
Cesk Slov Oftalmol; 2013 Mar; 69(1):41-4. PubMed ID: 23822601
[TBL] [Abstract][Full Text] [Related]
9. Effects of benzalkonium chloride- or polyquad-preserved fixed combination glaucoma medications on human trabecular meshwork cells.
Ammar DA; Kahook MY
Mol Vis; 2011; 17():1806-13. PubMed ID: 21750606
[TBL] [Abstract][Full Text] [Related]
10. Conjunctival changes induced by prostaglandin analogues and timolol maleate: a histomorphometric study.
Russ HH; Costa VP; Ferreira FM; Valgas SR; Correa Neto MA; Strobel Ev; Truppel JH
Arq Bras Oftalmol; 2007; 70(6):910-6. PubMed ID: 18235898
[TBL] [Abstract][Full Text] [Related]
11. Reduced in vivo ocular surface toxicity with polyquad-preserved travoprost versus benzalkonium-preserved travoprost or latanoprost ophthalmic solutions.
Liang H; Brignole-Baudouin F; Riancho L; Baudouin C
Ophthalmic Res; 2012; 48(2):89-101. PubMed ID: 22473057
[TBL] [Abstract][Full Text] [Related]
12. Improvement of the ocular bioavailability of timolol by sorbic acid.
Higashiyama M; Inada K; Ohtori A; Tojo K
Int J Pharm; 2004 Mar; 272(1-2):91-8. PubMed ID: 15019072
[TBL] [Abstract][Full Text] [Related]
13. Decrease in Corneal Damage due to Benzalkonium Chloride by the Addition of Mannitol into Timolol Maleate Eye Drops.
Nagai N; Yoshioka C; Tanino T; Ito Y; Okamoto N; Shimomura Y
J Oleo Sci; 2015; 64(7):743-50. PubMed ID: 26136174
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of preserved and unpreserved formulations of timolol on the ocular surface of albino rabbits.
Pisella PJ; Fillacier K; Elena PP; Debbasch C; Baudouin C
Ophthalmic Res; 2000; 32(1):3-8. PubMed ID: 10657748
[TBL] [Abstract][Full Text] [Related]
15. [Benzalkonium chloride daily dose--an important criterion in glaucoma treatment].
Výborný P; Sicáková S
Cesk Slov Oftalmol; 2011 Apr; 67(2):63-6. PubMed ID: 21751744
[TBL] [Abstract][Full Text] [Related]
16. Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears.
Kahook MY; Noecker RJ
Cornea; 2008 Apr; 27(3):339-43. PubMed ID: 18362664
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Cytotoxic Effects on Rabbit Corneal Endothelium between Preservative-free and Preservative-containing Dorzolamide/timolol.
Kwon J; Heo JH; Kim HM; Song JS
Korean J Ophthalmol; 2015 Oct; 29(5):344-50. PubMed ID: 26457041
[TBL] [Abstract][Full Text] [Related]
18. In vivo evaluation and in-depth pharmaceutical characterization of a rapidly dissolving solid ocular matrix for the topical delivery of timolol maleate in the rabbit eye model.
Moosa RM; Choonara YE; du Toit LC; Tomar LK; Tyagi C; Kumar P; Carmichael TR; Pillay V
Int J Pharm; 2014 May; 466(1-2):296-306. PubMed ID: 24607446
[TBL] [Abstract][Full Text] [Related]
19. Rapid and selective removal of preservative from ophthalmic formulations during eyedrops instillation.
Hsu KH; Chauhan A
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):30-8. PubMed ID: 26459089
[TBL] [Abstract][Full Text] [Related]
20. Promoting effect of borneol on the permeability of puerarin eye drops and timolol maleate eye drops through the cornea in vitro.
Wu CJ; Huang QW; Qi HY; Guo P; Hou SX
Pharmazie; 2006 Sep; 61(9):783-8. PubMed ID: 17020156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
